Sarah Danson is a researcher at Sheffield Teaching Hospital NHS Foundation Trust. Her clinical and research interests are in the treatment of melanoma and lung cancer, and in the early clinical assessment of new anticancer agents. Sheffield is an `Experimental Cancer Medicine Centre´ and its aims are to expand the early clinical trial portfolio and produce associated translational work.